Donor Pool Size Matters for Allogeneic Cell Therapies

Contact our team to start building your solution

To identify a sufficient number of donors who meet study eligibility, health authority and medical suitability requirements, a large donor pool is required even for the most common HLA genotypes. Choose a partner whose registry size and diversity are built to scale with you.

Discover how accessing the largest, most diverse, registry of potential donors in the world can help you minimize your risk and consistently obtain allogeneic source material you can count on.